|
Market Cap (17-May) $40,671,720 (1,053rd) |
Close (30-Jun) $0.125 |
Volume (30-Jun) 400,697 |
Shortsold (10-Dec) 1,128,575 (0.62%) (255th) |
|
52w High $0.345 |
52w Low $0.140 |
P/E - |
EPS -0.05 |
A news article has been posted about Cynata Therapeutics on the AFR. The article was published around , on 11 July 2022 at 9:14am.
Cynata Therapeutics boss Dr Ross Macdonald likes to think outside the box when solving problems. Where better to do so than off the coast?
Read ArticleCYP was $0.37 at the close of trade on 08 July 2022
| Recent Articles about ASX:CYP | |
|---|---|
| 26-Apr | CYP:ASX Announcement - Promising Preclinical Heart Disease ...
company-announcements.afr.com |
| 26-Apr | Cynata to Present at Euroz Hartleys Healthcare Forum
company-announcements.afr.com |
| 20-Mar | CYP-006TK Demonstrates Safety and Efficacy in DFU Clinical Trial
company-announcements.afr.com |
| 12-Mar | CYP:ASX Announcement - Application for quotation of securities ...
company-announcements.afr.com |
| 10-Jan | CYP:ASX Announcement - First Kidney Transplant Trial Patient ...
company-announcements.afr.com |
| 31-Dec | Cynata Therapeutics Sees Change in Substantial Shareholder Voting Power
markets.businessinsider.com |
| 20-Dec | Cynata Therapeutics Announces Key Shareholder Meeting and Trial Updates
markets.businessinsider.com |
| 20-Dec | Cynata Therapeutics Announces Key Shareholder Meeting and Trial Updates
nasdaq.com |
| 18-Dec | Cynata Therapeutics Ltd (CYP)
au.investing.com |
| 18-Dec | Cynata Therapeutics Ltd
morningstar.com.au |
| Tracked |
Find all articles about Cynata Therapeutics, including others on the AFR, on the media page.
You must be logged in to post a reply.
Cynata Therapeutics 